What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Disease
Internal medicine, Endocrinology, Fatty liver, Gastroenterology and Nonalcoholic fatty liver disease are his primary areas of study.
Much of his study explores Internal medicine relationship to Diabetes mellitus.
As a part of the same scientific family, Giulio Marchesini mostly works in the field of Endocrinology, focusing on Randomized controlled trial and, on occasion, Placebo and Clinical trial.
Giulio Marchesini studies Fatty liver, namely Steatohepatitis.
His Gastroenterology research includes themes of Odds ratio, Biopsy, Hepatitis C and Risk factor.
The study incorporates disciplines such as Hemochromatosis, Lipogenesis, Liver biopsy, Hepatic fibrosis and Hepatology in addition to Nonalcoholic fatty liver disease.
His most cited work include:
- Nonalcoholic fatty liver disease a feature of the metabolic syndrome (1996 citations)
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (1673 citations)
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD (1634 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Gastroenterology, Cirrhosis and Fatty liver.
In his study, which falls under the umbrella issue of Internal medicine, Intensive care medicine is strongly linked to Diabetes mellitus.
Endocrinology is closely attributed to Amino acid in his work.
His work in Gastroenterology covers topics such as Odds ratio which are related to areas like Confidence interval.
Giulio Marchesini combines subjects such as Hepatocellular carcinoma and Liver function with his study of Cirrhosis.
Giulio Marchesini focuses mostly in the field of Fatty liver, narrowing it down to topics relating to Weight loss and, in certain cases, Binge eating.
He most often published in these fields:
- Internal medicine (61.87%)
- Endocrinology (33.06%)
- Gastroenterology (23.33%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (61.87%)
- Fatty liver (18.05%)
- Diabetes mellitus (17.04%)
In recent papers he was focusing on the following fields of study:
Giulio Marchesini mainly focuses on Internal medicine, Fatty liver, Diabetes mellitus, Nonalcoholic fatty liver disease and Gastroenterology.
His Internal medicine research incorporates elements of Endocrinology and Type 2 diabetes.
His studies in Fatty liver integrate themes in fields like Steatosis and Hepatology.
His Diabetes mellitus study combines topics from a wide range of disciplines, such as Insulin, Pediatrics and Emergency medicine.
The various areas that he examines in his Nonalcoholic fatty liver disease study include Lipogenesis, Metabolic syndrome, Liver transplantation and Lipotoxicity.
His research integrates issues of Overweight, Biopsy and Severity of illness in his study of Gastroenterology.
Between 2015 and 2021, his most popular works were:
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (1673 citations)
- Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 (328 citations)
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial (237 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Disease
His primary areas of study are Internal medicine, Fatty liver, Nonalcoholic fatty liver disease, Liver disease and Endocrinology.
His research in Internal medicine intersects with topics in Gastroenterology and Type 2 diabetes.
His Fatty liver study improves the overall literature in Disease.
His work deals with themes such as Cirrhosis and Liver transplantation, which intersect with Nonalcoholic fatty liver disease.
Giulio Marchesini has researched Liver disease in several fields, including Diabetes mellitus, Metabolic syndrome, Insulin resistance and Hepatic encephalopathy.
His research in Endocrinology focuses on subjects like Gut flora, which are connected to Adiponutrin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
